Endo, Makoto
Setsu, Nokitaka
Fujiwara, Toshifumi
Ishii, Takeaki
Nakagawa, Makoto
Yahiro, Kenichiro
Kimura, Atsushi
Shimada, Eijiro
Nakashima, Yasuharu
Matsumoto, Yoshihiro
Article History
First Online: 25 May 2019
Compliance with Ethical Standards
:
: Makoto Endo has received compensation from Taisho Toyama Pharmaceutical Co., Ltd., Daiichi Sankyo, Eli Lilly and Company, Eisai, and Novartis for service as a consultant or a speaker.Nokitaka Setsu declares that he has no conflict of interest.Toshifumi Fujiwara declares that he has no conflict of interest.Takeaki Ishii declares that he has no conflict of interest.Makoto Nakagawa declares that he has no conflict of interest.Kenichiro Yahiro declares that he has no conflict of interest.Atsushi Kimura declares that he has no conflict of interest.Eijiro Shimada declares that he has no conflict of interest.Yasuharu Nakashima has received research funding from Kyocera and Eisai, and has received speaker’s honoraria from Zimmer Biomet, Chugai Pharmaceutical, Mitsubishi Tanabe Pharma, Janssen Pharmaceuticals, Eisai, AbbVie, Bristol-Myers Squibb, Astellas, Hisamitsu Pharmaceutical Co., Inc., and Taisho Toyama Pharmaceutical Co., Ltd.Yoshihiro Matsumoto declares that he has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.